Piritrexim

Piritrexim

SCHEMBL28201443

C1CCOCC1.COc1ccc(OC)c(Cc2cnc3nc(N)nc(N)c3c2C)c1.Cl.[Pu]

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DHFR

The experimentally established mechanism targets of Piritrexim. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DHFR known ✓ P00374 5/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piritrexim SCHEMBL9687400 0.91 DHFR (0.98) DHFR
Piritrexim SCHEMBL29462191 0.89 DHFR (1.00) DHFR
Piritrexim SCHEMBL8124 0.89 DHFR (1.00) DHFR
Piritrexim SCHEMBL29365922 0.89 DHFR (1.00) DHFR
Piritrexim SCHEMBL135624 0.79 DHFR (0.79) DHFR
SCHEMBL10644572 0.78 DHFR (0.78) DHFR
SCHEMBL10644399 0.78 DHFR (0.78) DHFR
Trimetrexate SCHEMBL6013903 0.75 DHFR (0.70) DHFR
SCHEMBL11006578 0.74 DHFR (0.71) DHFR
SCHEMBL10465187 0.72 DHFR (0.67) DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107735097-A Extracellular matrix composition for treating cancer or immunity disease 希斯托金公司 2018-02-23 CN disclosed